HomeSRPT • NASDAQ
Sarepta Therapeutics Inc
add
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 611.09M | 68.38% |
Operating expense | 138.56M | -0.60% |
Net income | 196.89M | 2,947.86% |
Net profit margin | 32.22 | 1,710.11% |
Earnings per share | 2.02 | 359.09% |
EBITDA | 126.42M | 1,476.67% |
Effective tax rate | -28.15% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 800.14M | -45.21% |
Total assets | 3.68B | 7.46% |
Total liabilities | 2.32B | -1.05% |
Total equity | 1.36B | — |
Shares outstanding | 97.71M | — |
Price to book | 1.51 | — |
Return on assets | 8.09% | — |
Return on capital | 11.07% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 196.89M | 2,947.86% |
Cash from operations | 261.34M | 1,649.01% |
Cash from investing | 32.21M | 132.69% |
Cash from financing | -23.82M | -159.66% |
Net change in cash | 269.73M | 717.69% |
Free cash flow | 454.69M | 1,643.42% |
Previous close
$20.99
Day range
$20.20 - $21.08
Year range
$10.42 - $144.22
Market cap
2.01B USD
Avg Volume
17.67M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Sarepta Therapeutics, Inc. is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States. Incorporated in 1980 as AntiVirals, shortly before going public the company changed its name from AntiVirals to AVI BioPharma soon with stock symbol AVII and in July 2012 changed name from AVI BioPharma to Sarepta Therapeutics and SRPT respectively. As of 2023, the company has four approved drugs. Wikipedia
Founded
1980
Website
Employees
1,372
